NCT03210220

Brief Summary

The purpose of this study is to determine whether pectoral nerves blocks(PECS) would reduces the opioid consumption during the surgery and postoperative pain after breast cancer surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 29, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
4 months until next milestone

Results Posted

Study results publicly available

November 18, 2019

Completed
Last Updated

November 18, 2019

Status Verified

October 1, 2019

Enrollment Period

1.3 years

First QC Date

July 4, 2017

Results QC Date

September 16, 2019

Last Update Submit

October 28, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative Remifentanil Consumption

    Intraoperative remifentanil consumption during surgery(whole intraoperative period)

    whole intraoperative period

Study Arms (2)

pecs group

EXPERIMENTAL

Ultrasound guided pectoral nerve block is performed right after induction, before surgery. The needle is advanced to the tissue plane between the pectoralis major and pectoralis minor muscle at the vicinity of the pectoral branch of the acromiothoracic artery, and 10 mL of 0.5% ropivacaine deposited. In a similar manner, 20 mL is deposited at the level of the third rib between the pectoralis minor muscle and the serratus anterior muscle .

Procedure: Pecs II block

control group

NO INTERVENTION

There is no block.

Interventions

Pecs II blockPROCEDURE

After identifying the axillary vein and artery, the ultrasound probe was positioned inferio-laterally, between the 3rd and 4th ribs, and then the pectoralis major and minor, and serratus anterior muscles were confirmed. The needle was advanced in a medio-lateral direction in-plane view of the ultrasound. For the Pecs II block, a total 30 mL of 0.5% ropivacaine was injected. First, the needle tip was advanced into the fascia between the pectoralis major and minor muscles and 10 mL of 0.5% ropivacaine was injected. Thereafter, the needle tip was advanced into the tissue plane between the pectoralis minor and serratus anterior muscles, and 20 mL of 0.5% ropivacaine was injected in a similar manner.

pecs group

Eligibility Criteria

Age20 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists( ASA) I or II Scheduled for breast cancer surgery

You may not qualify if:

  • Sensitivity to local anesthetic, Bleeding disorders , Receiving anticoagulant, Body mass index (BMI) \> 35/kg/m2 , Spine or chest wall deformity , Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Cheon Lee

Incheon, 22241, South Korea

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Dr Junju Choi
Organization
Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University

Study Officials

  • Kyung Cheon Lee

    Gachon University Gil Medical Center

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
One anesthesiologist (JJC) performed all blocks in the Pecs group enrolled patients. After the intervention, the participants and the investigator responsible for the study outcome assessment were blinded.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Patients either received the Pecs II block (Pecs group) or did not receive it (control group).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistance professor

Study Record Dates

First Submitted

July 4, 2017

First Posted

July 6, 2017

Study Start

August 29, 2017

Primary Completion

December 30, 2018

Study Completion

August 1, 2019

Last Updated

November 18, 2019

Results First Posted

November 18, 2019

Record last verified: 2019-10

Locations